Company Filing History:
Years Active: 2023-2025
Title: Innovations of Hangzhou Shen in Pharmaceutical Development
Introduction
Hangzhou Shen is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of capsid protein assembly inhibitors. With a total of 3 patents, his work focuses on innovative solutions for treating diseases caused by viral infections.
Latest Patents
Hangzhou Shen's latest patents include groundbreaking compounds aimed at combating hepatitis B virus infections. One of his notable inventions is the "N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof." This patent provides a compound of formula I or II, which includes various forms such as stereoisomers and prodrugs, along with its medical applications. Another patent with a similar focus emphasizes the use of these compounds in treating diseases benefiting from capsid protein assembly inhibitors, specifically targeting hepatitis B virus infections.
Career Highlights
Hangzhou Shen is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from viral infections. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Some of his notable coworkers include Yinsheng Zhang and Wangwei Ao, who contribute to the collaborative efforts in their research projects. Their combined expertise enhances the potential for innovative breakthroughs in pharmaceutical development.
Conclusion
Hangzhou Shen's contributions to the field of pharmaceuticals, particularly through his patents, demonstrate his commitment to advancing medical science. His innovative work in developing capsid protein assembly inhibitors is paving the way for new treatments for viral infections.